David Bautz
Recent Quotes
"Sales of VIV's OxC-beta should begin to increase throughout 2022."
—
David Bautz, Zacks Small-Cap Research
(1/31/22)
more >
"We are very encouraged how VIV continues to expand its customer base and increase the size and frequency of orders for OxC-beta Livestock."
—
David Bautz, Zacks Small-Cap Research
(6/14/21)
more >
Due to permission requirements, not all quotes are shown.